As we all know, COVID-19 is a respiratory illness that has rapidly spread across the globe. It presents similarly to Influenza, with symptoms including fever, headache, chills, muscle or joint pain, fatigue, cough, sore throat, and nasal congestion. For some people, infection with Influenza or COVID-19 can have severe consequences including hospitalisation or death.

Every year, Influenza vaccines are tailored to target the currently circulating strains of the virus. It is possible that we will need a similar approach to prevention of the COVID-19 virus, with an annual booster dose required to provide ongoing protection.

Here at AusTrials, we are conducting a clinical research study testing an investigational combination vaccine being developed to prevent both Influenza and COVID-19 infection. The goal of this study is to test the safety and immune response to the experimental combination vaccine using a single vaccination approach. Both the influenza and COVID-19 components of the investigational vaccine have separately demonstrated a favorable safety profile.

The investigational combination vaccine will be given as a ‘booster’ for those who have previously been vaccinated against COVID-19 or have previously been infected.

The study involves up to three vaccinations and eight visits to our dedicated research facility over the span of 6 months. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you:

• are 50 to 70 years of age

AND

• have completed a full course of COVID-19 vaccination at least 2 months ago

OR

• were confirmed to have been infected with COVID-19 at least 2 months ago

This study is being conducted at the following AusTrials location:

• Taringa, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get in touch.

Symptoms of flu-like illness can include fever, headache, chills, muscle or joint pain, fatigue, cough, sore throat, and nasal congestion. These symptoms can be caused by an excess release of inflammatory chemicals from cells of the immune system.

Here at AusTrials, we are running a clinical study testing a potential treatment for flu-like illness. The product being tested is already in use to treat allergic eye conditions by reducing the release of inflammatory chemicals.

The study involves 3 visits to our dedicated research facility and 1 follow-up phone call. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are:

• 18 to 64 years of age
• Currently experiencing a fever of at least 38 ºC
• Currently experiencing a headache, chills, muscle/joint pain, or fatigue along with a cough, sore throat, or nasal congestion

This study is being conducted at the following location:

• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get in touch.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Meningococcal Disease is rare, but can be sudden, potentially cause devastating lifelong impairments and can be fatal. Teens and young adults are at higher risk of infection.

Here at AusTrials, we are conducting a research study testing a potential new vaccine that may act as a booster for people who have already been vaccinated against Meningococcal Disease.

The study will involve four visits to our dedicated research facility in Taringa or Wellers Hill and up to five follow-up phone calls.

You may be eligible to take part if:

• You are healthy and between 15 and 25 years old
• You have previously been vaccinated against Meningococcal Disease

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Eligible participants will be compensated for their time and effort.

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Potential participants under 18 years old must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.

AusTrials are currently studying Papaw ointment as a potential treatment for skin conditions such as mild eczema and/or rash, cracked or dry skin on heels, insect bites and sunburn.

The study involves two visits to our dedicated research facility over a period of either 10 or 21 days. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are 18 to 50 years of age and currently experiencing mild eczema and/or rash, cracked or dry skin on heels, insect bites or sunburn.

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Anaemia is a decrease in red blood cells which can cause tiredness, weakness, shortness of breath and fatigue. There are many causes of anaemia in those over 65 years of age, including nutritional deficiencies and chronic inflammatory diseases. In some cases, an underlying reason cannot be found.

Here at AusTrials, we are running a clinical study testing a potential treatment for Anaemia of Ageing.

The study involves up to 16 visits to our dedicated research facility. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if:

• You are 65 years of age or older
• You have symptoms of anaemia (tiredness, weakness, shortness of breath and/or fatigue)

This study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Respiratory Syncytial Virus (RSV) is highly contagious and usually presents like a common cold. However, it can also cause more serious respiratory illness and can lead to complications in older adults, such as pneumonia. It can be fatal.

Here at AusTrials, we are running a clinical study testing a new vaccine which may prevent RSV infection in older adults.

The study involves visits to our dedicated research facilities, along with scheduled telephone contacts.

You may be eligible to participate if you are:

• 60 years of age or older

Eligible participants will receive vaccinations free of charge and will be paid for their time and effort.

The study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD
• Morayfield, QLD

Please contact AusTrials on 07 3278 5255 for further information or follow the link below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Vaccination is the main method for preventing the flu and its complications. In older adults, the body’s natural defence against infection can be weakened. This may make the currently available vaccines less effective.

Here at AusTrials, we are running a clinical study testing a potential new flu vaccine that has been designed to provide a stronger immune response.

The study involves up to three visits to our dedicated research facility and two scheduled telephone calls. Eligible participants will be compensated for their time and effort.

You may be eligible to participate if you are:

• 50 years of age or older

This study is being conducted at the following locations:

• Taringa
• Wellers Hill

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Low libido can cause significant distress and can have a negative impact on relationships. The official term is Hypoactive Sexual Desire Disorder (HSDD), and symptoms can include having a lack of interest or desire for sexual activity and reduced or absent sexual thoughts.

Here at AusTrials we are conducting a research study to test an investigational treatment for women who are affected with low libido or believe they may have Hypoactive Sexual Desire Disorder.

The study involves up to five visits to the clinic and five scheduled telephone calls. Eligible participants will be compensated $100 per clinic visit for their time and effort.

You may be eligible to participate if you are:

• female
• aged between 21 and 50 years (and are premenopausal)
• in a stable relationship

This study is being conducted at the following locations:

• Taringa
• Wellers Hill (Tarragindi)

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Osteoporosis is a ‘silent’ condition in which a loss of bone density increases the risk of serious fractures.

Here at AusTrials we are conducting an observational study in women over the age of 50 who have experienced a fracture due to their osteoporosis in the last 12 months, in comparison to women over the age of 50 who have not recently experienced a fracture.

The study aims to investigate the effects of osteoporotic fractures on productivity (in terms of decreased paid or unpaid work) and physical functioning during activities of daily living.

This study consists of a review of medical history and completion of a survey. Eligible participants will be compensated $50 for their time and effort.

The study is being conducted at three AusTrials clinics across Brisbane:

• Taringa
• Victoria Point
• Wellers Hill (Tarragindi)

Please contact AusTrials on 07 3278 5255 for further information or fill out the form below and we will get back to you. Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Diabetes can cause serious complications, including heart disease

If you have type 2 diabetes, consider joining a study to test a possible therapy for preventing heart damage caused by diabetes.

Key study entry requirements:

• Type 2 diabetes
• At least 40 years old

Note: Other criteria apply

Qualified study participants will receive:

• Potential access to an investigational study drug at no cost. Note: Some participants will receive a placebo (dummy pill)
• Study-related support and monitoring by a health care team
• Education about diabetic complications, including heart damage
• Reimbursement for time and travel

The study is being conducted at the following location:

• Taringa, QLD

Contact AusTrials on 07 3278 5255 for further information, visit https://clinicaltrials.gov/ct2/show/NCT04083339 or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Meningococcal disease is rare, but if contracted, it can progress suddenly. The disease can cause devastating lifelong impairments and can be fatal.

Currently, there are two available vaccines for Meningococcal disease. One vaccine protects against the A, C, W and Y strains and the other vaccine protects against the B strains of the disease. AusTrials is conducting a research study to test a new investigational vaccine that combines the 5 main strains of the disease into the one vaccine (ABCWY).

The study will involve 6 clinic visits over a 12-month period. Participants will be asked to give blood to assess how the body reacts to the vaccine, answer questions about participant health and complete an electronic diary to collect health information after vaccination. In total, participants will receive 4 injections (vaccines).

You may be eligible to take part if:

• You are healthy and between 10 and 25 years old
• You have never had a vaccine against any of the 5 Meningococcal strains (A, B, C, W or Y). However, you can still join the study if you received a Meningococcal C strain vaccine at or before 24 months of age.

The study is being conducted at the following locations:

• Taringa, QLD
• Wellers Hill, QLD

Qualified participants will receive:

• Vaccinations and visits at no cost
• Compensation for time and travel involved in the study

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.

Potential participants under 18 years must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.

Do you suffer from recurrent urinary tract infections (UTIs) or have symptoms?

Here at AusTrials we are studying a new antibiotic for the treatment of uncomplicated UTIs.

Participants will be randomised to either receive the study medication or another commonly used antibiotic called nitrofurantoin.

The study involves 4 visits to us at our Wellers Hill clinic over approximately a month.

Participants will receive either the study medication or nitrofurantoin twice daily for 5 days.

Compensation for the time and travel involved in the study may be available.

You may be eligible to take part in this study if you are:

• Female
• Adolescent or adult (aged 12 years and over)
• Experiencing symptoms of UTI in the last three days

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.

Share this study on social media or by email with friends or family who may be interested.

Potential participants under 18 years must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.

Have you been diagnosed with kidney disease due to your diabetes and are currently on a common blood pressure medication? If so, you may able to take part in a clinical study of a new treatment for people with type 2 diabetes that AusTrials is conducting at the Westside Private Hospital in Taringa.

You may be able to take part in the study if you are:

• 18 Years and older, of either sex
• Have type 2 diabetes
• Have been diagnosed with kidney disease (by finding protein in your urine)
• On one of two commonly used medications for your blood pressure

Medications ending in  –pril  eg. Enalapril, Captopril, etc

Medications ending in -sartan eg. Irbesartan, Candesartan etc

The study is being conducted at this location:

• Taringa, QLD

Qualified participants will receive:

• Study medications and visits at no cost
• Diabetes education – fully funded
• Compensation for time and travel involved in the study.

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this trial on social media or by email with friends or family who may be interested.

Do you have pain from osteoarthritis of the knee?   

Osteoarthritis is a common degenerative joint disorder. Treatment for OA primarily involves a combination of exercise and lifestyle modification, drug treatment, supplementation with glucosamine or chondroitin sulphate, and surgical joint replacement. Among drug treatments, corticosteroids are routinely given by an injection into the joint for the treatment of chronic knee joint diseases to relieve pain, reduce inflammation, and improve mobility. 

A limitation of such joint injection with corticosteroids is the modest duration of treatment effect, which often lasts for only 2 to 4 weeks. Repeat injections are possible in the same joint, but there are limited data on the safety and duration of the effectiveness of this procedure.  

AusTrials is conducting a clinical trial testing a new longer acting joint injection for osteoarthritis of the knee in patients who are still experiencing pain.  X-rays will be performed to see to assess the severity of any joint damage.  The study is assessing if the new corticosteroid injection provides both short-term and sustained pain and symptom relief for up to 6 months in patients with knee OA pain. 

You may be able to take part in the study if you: 

• Are 40 years of age or older, male or female  

• Have been diagnosed with knee osteoarthritis  
• Have continued to experience pain for at least 6 months  
• Have a normal to moderately high weight (Body Mass Index less than 40) 
• Are not using regular non-steroidal analgesic (eg ibuprofen) or some opioid medications. 

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.   

Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested. 

Now enrolling: a clinical study testing flu vaccine in children 6 months to less than 9 years of age 

Influenza is a highly infectious disease that occurs in epidemics throughout the winter months and can be severe in young children. The flu is characterised by the abrupt onset of respiratory and systemic symptoms, such as fever, myalgia, headache, severe malaise, non-productive cough, sore throat, and a runny nose.

Flu vaccines are designed to prevent the flu and may help keep babies and young children healthy during flu season. Vaccination is the most effective method to avoid contracting the flu.

This study will provide influenza vaccination to children from 6 months to less than 9 years of age who are otherwise healthy, have not had the influenza vaccine in the past 6 months and haven’t had a severe allergic reaction in the past when vaccinated.

The study is being conducted at these centres:

• North Ipswich, QLD

• Taringa, QLD

• Wellers Hill, QLD

• Victoria Point, QLD

Qualified participants and their parents will receive:

• Influenza immunisation with this season’s quadrivalent vaccine

• Reimbursement for time and travel

All study procedures are performed at NO COST.

Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.

Use the links at the bottom of the page to share this trial on social media or by email with friends or family who may be interested.

Potential participants under 18 years must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.